Aug 14, 2025
With 722% Revenue Growth Over Three Years, Alafair Biosciences Celebrates Its Third Appearance on the Inc. 5000 List
Jul 30, 2025
Alafair Biosciences Receives 510(k) Clearance for VersaCoat™ Tendon Protector and VersaCoat™ Nerve Protector
Jun 30, 2025
Alafair Biosciences Named to Inc.'s 2025 Best Workplaces List
May 07, 2025
Alafair Biosciences Ranked #2 on the 2025 Longhorn 100 List of Fastest-Growing Longhorn-Led Businesses
Apr 01, 2025
With 51% Year-over-Year Growth, Alafair Biosciences moves up 41 spots to No. 13 on the Inc. Regionals: Southwest List
Mar 11, 2025
Inc. Names Alafair Biosciences' Sarah Mayes, Ph.D. to Its 2025 Female Founders 500 List
Mar 05, 2025
Alafair Biosciences Reports Strong Growth in 2024
Dec 19, 2024
Alafair Biosciences Celebrates Over 22,000 Implants of VersaWrap® Hydrogel Sheet in Patients
Oct 18, 2024
Alafair Biosciences CEO John Joyoprayitno Wins 2024 Austin Business Journal's Best CEO Award
Sep 16, 2024
Alafair Biosciences to Exhibit VersaWrap®, Recently Awarded an Innovative Technology Contract, at the Vizient® Innovative Technology Exchange
Aug 13, 2024
For the Second Year, Alafair Biosciences Makes Inc. 5000, With Three-Year Revenue Growth of 597%
Jul 02, 2024
Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet
Mar 07, 2024
Alafair Biosciences reports record-breaking 2023 business results
Sep 24, 2020
Alafair Biosciences Receives 510(k) Clearance for VersaWrap® Nerve Protector